Core Viewpoint - Huajian Medical (01931) is in discussions regarding a potential control transaction involving Chuangye Huikang Technology Co., Ltd. (Chuangye Huikang) and its largest shareholder, Ge Hang [1] Group 1: Company Information - Huajian Medical has established a limited partnership enterprise in China, named Hangzhou Genghao Zhito Management Consulting Partnership (Limited Partnership), funded by its subsidiary [1] - Chuangye Huikang is a joint-stock company registered in China, listed on the Shenzhen Stock Exchange's ChiNext board [1] Group 2: Transaction Details - As of the date of the announcement, all parties are still discussing the specific terms of the potential transaction, including but not limited to transaction structure, cost, timeline, and preconditions [1] - The final terms of the potential transaction will require further negotiations and the signing of a formal agreement among the relevant parties [1]
华检医疗(01931):杭州更好智投管理咨询正筹划收购创业慧康控制权